Pharmacokinetics of intravenously administered aminophylline in children. 1982

M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007700 Kinetics The rate dynamics in chemical or physical systems.
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000628 Aminophylline A drug combination that contains THEOPHYLLINE and ethylenediamine. It is more soluble in water than theophylline but has similar pharmacologic actions. It's most common use is in bronchial asthma, but it has been investigated for several other applications. Afonilum,Aminodur,Aminophyllin,Aminophylline DF,Cardophyllin,Carine,Clonofilin,Corophyllin,Diaphyllin,Drafilyn,Duraphyllin,Eufilina,Eufilina Venosa,Euphyllin,Euphyllin Retard,Euphylline,Godafilin,Mini-Lix,Mundiphyllin,Mundiphyllin Retard,Novophyllin,Phyllocontin,Phyllotemp,Somophyllin,Tari-Dog,Theophyllamin Jenapharm,Theophyllamine,Theophyllin EDA-ratiopharm,Theophylline Ethylenediamine,Truphylline,Ethylenediamine, Theophylline,Theophyllin EDA ratiopharm,Theophyllin EDAratiopharm
D001249 Asthma A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). Asthma, Bronchial,Bronchial Asthma,Asthmas

Related Publications

M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
May 1970, The Journal of pediatrics,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
June 1983, The Journal of pediatrics,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
June 1987, Journal of veterinary pharmacology and therapeutics,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
May 1983, The American review of respiratory disease,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
January 1978, Anesthesia and analgesia,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
August 1984, Antimicrobial agents and chemotherapy,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
June 1978, British journal of pharmacology,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
July 1975, Southern medical journal,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
August 1997, Antimicrobial agents and chemotherapy,
M Rao, and P Steiner, and M S Victoria, and H Jabbar, and R Maraya
September 1986, British journal of clinical pharmacology,
Copied contents to your clipboard!